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doi:10.1016/j.pedneo.2011.03.005Background: The purposes of this study were to characterize the symptoms and signs of chil-
dren with myocarditis at the time of presentation to the hospital and to identify the predictors
of death.
Methods: This was a 5-year retrospective study in a tertiary hospital. We collected demo-
graphic data and clinical symptoms and signs when children with myocarditis presented at
the hospital. The outcome for patient was classified as either survival or death, and the predic-
tors of death were identified.
Results: Over the 5-year period, 27 children (14 boys and 13 girls) met the definition of clinical
myocarditis. The mean age of the myocarditis patients was 9.1 5.1 years (range, 0.08e17.9
years), and the maximum age was 10e12 years. The most common presentation was gastroin-
testinal symptoms. We used extracorporeal membrane oxygenation on nine (33%) children, and
pacemaker was implanted in eight (30%). Six (22%) children died in this study, and only one of
them was younger than 6 years. The poor prognosis predictors were gastrointestinal symptoms,
hepatomegaly, and hypotension.
Conclusions: Pediatric myocarditis presents primarily with gastrointestinal symptoms in
Taiwan. Careful check of heart rhythm may provide a useful objective marker of myocarditis.Pediatric Critical Care and Emergency Medicine, Department of Pediatrics, Chang Gung Children’s
spital at Linkou, Chang Gung University College of Medicine, #5 Fu-Hsing Street, Kweishan, Taoyuan
rg.tw (S.-H. Hsia).
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reserved.Figure 1 Age distribution of the children with myocarditis.1. Introduction
Myocarditis, an inflammation of myocardial tissue, is a rare
but fatal disease.1,2 Myocarditis is difficult to diagnose
because its clinical presentation is nonspecific and incon-
sistent,3 and misdiagnosis may lead to lawsuits in which the
settlement may reach millions of US dollars.4 One study
investigated the relative frequencies of various presenting
symptoms to provide clinic-based physicians with epidemio-
logical data to guidemanagement decisions in the evaluation
and treatment of children with myocarditis. However, the
authors classified children into presentation groups based on
a single symptom,5 whereas many children had more than
one symptom; therefore, this study may not reflect the real
presentation at the emergency department (ED). In the ED,
physicians should consider all clinical symptoms and signs,
not exclusively those in one group of diseases.
Characterizing the signs and symptoms of children with
myocarditis might facilitate earlier diagnosis of the
disease,6 and children with myocarditis might benefit from
the early administration of intravenous immunoglobulin7
(IVIG) and institution of mechanical circulatory support.8,9
This study characterized the symptoms, signs, and labora-
tory results of children with myocarditis at the time of
presentation at the hospital and identified the predictors of
death among pediatric myocarditis patients in Taiwan.
2. Patients and Methods
Chang Gung Memorial Hospital is a tertiary care hospital in
Taiwan. It serves patients from a broad demographic spec-
trum and a geographic region that includes urban, suburban,
and rural areas. We retrospectively reviewed the charts of
children younger than 18 years who initially visited our insti-
tution’s ED and were diagnosed with myocarditis between
January 2004 and December 2008. Patients were identified
by searching the hospital database for all children who had
an International Classification of Diseases, Ninth Revision,
Clinical Modification discharge diagnostic code correspond-
ing tomyocarditis (422, acutemyocarditis; 074.23, coxsackie
myocarditis; 429.0, unspecific myocarditis).
Myocarditis was diagnosed by attending pediatric cardi-
ologists if clinical symptoms compatible with myocarditis
were observed along with at least one of the following:
elevated troponin I (>0.1 ng/mL)10; cardiomegaly (cardio-
thoracic ratio, >0.5) on the chest radiograph, or impaired
heart contractility on echocardiography (ejection fraction
<55%). The exclusion criterion was children with congenital
heart disease or enterovirus 71 infections with central
nervous system involvement proved by brain magnetic
resonance imaging.
Each patient’s demographic characteristics, medical
history, vital signs, physical examination results, laboratoryvariables, and outcome were abstracted from an electronic
database. We classified the ED clinical presentations into five
groups: respiratory (shortness of breath), gastrointestinal
(abdominal pain or vomiting), cardiac (chest pain or palpi-
tations), hypoperfusion (syncope or seizure), and fever.
SPSS for Windows version 14.0 (SPSS Inc., Chicago, IL,
USA) was used for data analysis. Frequencies were calcu-
lated for demographic variables, variables from the history
and physical examination, and outcomes. For the purpose
of the analyses, children were dichotomized into younger
(age, 0e5 years) and older (age, 6e18 years) groups. The
primary result was the frequency of ED presenting symp-
toms, signs in children with myocarditis. The outcome for
the children was classified as either survival or death.
Fisher’s exact test was used to check categorical data. All
statistical tests were evaluated at the 5% significance level.
The odds ratio (OR) with 95% confidence interval (CI) was
also estimated.
3. Results
Over the 5-year study period, 224,435 patients were seen in
the pediatric ED of Chang Gung Memorial Hospital. A chart
review revealed that only 27 (14 boys and 13 girls) met the
definition of clinical myocarditis. Therefore, the incidence
of children presenting with myocarditis at our institution’s
ED was 1.2 cases per 10,000 visits. The mean age of the
myocarditis patients was 9.1 5.1 years (range, 0.08e17.9
years), and the maximum age was 10e12 years; the age
distribution is shown in Figure 1.
The clinical symptoms and signs are summarized in
Tables 1 and 2, respectively. A variety of clinical presenta-
tions was observed. The most common symptom group was
the gastrointestinal group; 11 (41%) of 27 children had
gastrointestinal symptoms, and all but one of these children
Table 2 Signs on admission and univariate analysis of
prognostic factors in the 27 children between 2004 and 2008
Variable No. of patients Odds ratio (95% CI) p
Survival
(nZ 21)
Death
(nZ 6)
Tachycardia
Yes 12 5 3.73 (0.37e37.95) 0.36
No 9 1 1 e
Respiratory distress
Yes 7 3 2.00 (0.32e12.59) 0.64
No 14 3 1 e
Lethargy
Yes 9 3 1.33 (0.22e8.22) 1.00
No 12 3 1 e
Abnormal heart sound
Yes 5 2 1.60 (0.22e11.50) 0.63
No 16 4 1 e
Hepatomegaly
Yes 4 4 8.50 (1.13e63.87) 0.044
No 17 2 1 e
Hypotension
Yes 1 3 20.00 (1.53e260.79) 0.025
No 20 3 1 e
Peripheral edema
Yes 1 2 10.00 (0.72e138.68) 0.12
No 20 4 1 e
Cyanosis
Yes 0 2 0.043
No 21 4
Table 1 Symptoms on admission and univariate analysis
of prognostic factors in the 27 children between 2004 and
2008
Variable No. of patients Odds ratio (95% CI) p
Survival
(nZ 21)
Death
(nZ 6)
Symptoms
Respiratory (shortness of breath)
Yes 7 3 2.00 (0.32e12.59) 0.64
No 14 3 1 e
Gastrointestinal (abdominal pain or vomiting)
Yes 6 5 12.50 (1.20e130.61) 0.027
No 15 1 1 e
Cardiac (chest pain or palpitations)
Yes 4 1 0.85 (0.077e9.44) 1.00
No 17 5 1 e
Hypoperfusion (syncope or seizure)
Yes 7 2 1.00 (0.15e6.85) 1.00
No 14 4 1 e
Fever
Yes 9 1 0.27 (0.03e2.70) 0.36
No 12 5 1 e
Pediatric myocarditis in Taiwan 137were older than 6 years. On physical examination, the most
common sign was tachycardia; 17 (63%) had tachycardia. The
laboratory results are summarized in Table 3. Among the
laboratory tests studied, except creatine phosphokinase and
troponin I, aspartate aminotransferasemeasurementwas the
most sensitive (sensitivity, 59%).
Twenty-three (85%) children had to be given inotropic
agents, including dopamine, epinephrine, milrinone, or
norepinephrine, while hospitalized. The treatments given
to the other four patients were fluid restriction, diuretic
use, and IVIG. IVIG was prescribed in 18 (67%) children. We
used extracorporeal membrane oxygenation on nine (33%)
children, and pacemaker was implanted in eight (30%)
children. Six children died in this study, and only one of
these was younger than 6 years; among them, four children
died in our hospital and two children died while waiting for
heart transplantation. The average hospitalization duration
was 18.52 13.47 days. For the survivors, the average
follow-up duration was 23.43 16.30 months. One patient
required peritoneal dialysis to treat renal failure, and the
others are alive without complications.
The significant predictors of poor outcome were
gastrointestinal symptoms, hepatomegaly, and hypoten-
sion. Eleven (41%) of the 27 children had gastrointestinal
symptoms (ORZ 12.57, 95% CIZ 1.20e130.61, pZ 0.027);
eight (30%) had hepatomegaly (ORZ 8.50, 95%
CIZ 1.13e63.87, pZ 0.044); and four (15%) had hypoten-
sion (ORZ 1.53, 95% CIZ 1.53e260.79, pZ 0.025). Age
and sex were not significantly associated with death.
4. Discussion
Myocarditis is the inflammation of the muscular walls of
the heart.1,2 The initial diagnosis of myocarditis is highlydependent on clinical suspicion because a diagnosis based
on an endomyocardial biopsy has many inherent risks;
consequently, biopsies are not performed routinely.1,5,6
However, clinical and experimental data suggest that, in
myocarditis, elevated troponin I levels reflecting myocar-
dial injury precede the occurrence of inflammation, and
troponin I is frequently measured whenever myocarditis is
considered clinically.10
This study examined a series of 27 children diagnosed
with myocarditis at a tertiary hospital in Taiwan. The most
common presenting symptom was gastrointestinal
complaints, which differed from those of previous
studies.5,6 One reason for this difference may be that our
study considered all of the children’s complaints in the ED,
not just those exclusive to one symptom group. Our method
was similar to that in clinical practice, in which physicians
must consider all complaints and not artificially classify
children into a disease group. In addition, differences in
age distribution may play an important role; older children
and adolescents with heart failure may have primarily
abdominal symptoms and a surprising lack of respiratory
complaints.11 A potential explanation for this finding is that
older children and adolescents are able to verbalize that
they have abdominal pain.
Patients with myocarditis may have only nonspecific
complaints; if these symptoms are associated with more
Table 3 Initial laboratory results for myocarditis cases (nZ 27)
Laboratory tests Death (nZ 6) Survival (nZ 21)
No. of
samples
Parameter Proportion
abnormal, %
No. of
samples
Parameter Proportion
abnormal, %
Median Range* Median Range*
WBC,  109 cells per L 6 9.4 8.7e11.4 17 21 10.4 8.9e13.1 29
Hb, g/dL 6 13.0 11.4e13.9 17 21 13.0 12.2e13.9 10
CRP, mg/L 6 10.0 2.0e17.9 50 18 9.0 3.3e77.0 61
ALT, U/L 6 95 67e185 83 20 46 21e196 35
AST, U/L 6 226 112e498 83 21 138 35e230 52
BUN, mg/L 6 30 21e38 50 21 17 10e34 29
Creatinine, mg/L 6 1.0 1.2e1.7 50 20 1.0 0.6e1.0 10
* Ranges are reported as 25the75th percentile.
WBCZwhite blood cell count; HbZ hemoglobin; CRPZ C-reactive protein; ALTZ alanine aminotransferase; ASTZ aspartate
aminotransferase; BUNZ blood urea nitrogen.
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dyspnea, or exercise intolerance, myocarditis is more likely
to be suspected.12,13 This is why the diagnosis is often
delayed in those patients presenting with gastrointestinal
symptoms. Early, prompt diagnosis and management may
be of benefit.7e9 In addition, children with gastrointestinal
symptoms are often given excessive intravenous fluids,
which may exacerbate the heart failure.11,14 This can
explain why gastrointestinal symptoms were a poor prog-
nosis predictor in our series.
Although many clinicians believe that resting tachy-
cardia is a common finding in patients with myocarditis, we
found that 37% of the children had a normal heart rate for
their age. Normal heart rates in children with myocarditis
were seen in 42e66% of the patients in two reports.5,6
Therefore, a single heart rate measurement may not be
a useful objective marker of myocarditis.6 Carefully
checking a child’s heart rate is still very important, espe-
cially in those patients with an irregular heart rhythm.15,16
Deaths from complete atrioventricular block leading to
ventricular arrest have been reported.16
Our study revealed that gastrointestinal symptoms,
hypotension, and hepatomegaly predicted a poor prognosis.
However, gastrointestinal symptoms are one of most
common complaints at ED; very few children have gastro-
intestinal symptoms because of myocarditis. Therefore, to
do workup in every patient with vomiting and diarrhea for
myocarditis may have a very low yield and high expense.
This study has some limitations. First, the lack of
unequivocal diagnostic criteria allows one to question the
diagnosis of myocarditis; this is not unique to this study.5,17
Second, we wanted to investigate the period from when the
first symptom appeared to the start of management and the
relationship between this interval and outcome. However,
most children and parents could not clearly state when
their symptoms began. This is because myocarditis prog-
resses through stages with distinctly different mechanisms
and manifestations.18 Third, because our series of patients
was collected at a single tertiary care, academic pediatric
hospital, the findings may not be completely representative
of the general population. A population-based study is
needed.5. Conclusion
Pediatric myocarditis presents primarily with gastrointes-
tinal symptoms in Taiwan. Careful checking of heart rhythm
may be a useful objective marker of myocarditis. The
predictors of a poor prognosis were gastrointestinal symp-
toms, hepatomegaly, and hypotension.References
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